Dupharma / STAMICIS

Forside

Udskriv

CALL US NOW: +45 32 50 66 10

Dupharma A/S

Dupharma A/S

Dupharma A/S

Dupharma A/S

Dupharma A/S

Dupharma A/S

Dupharma A/S

STAMICIS^{®

Kit for the preparation of technetium (^99mTc) sestamibi injection}

Isotope	Technetium (^99mTc)
Number of radiolabelled preparations	5
Each vial contains : Tetrakis (2-methoxy isobutyl isonitrile) copper (I) tetrafluoroborate (Cu (MIBI)4 BF4): Stannous chloride dihydrate. L-cysteine hydrochloride monohydrate. Sodium Citrate Dihydrate Mannitol	1 mg 0.075 mg 1.0 mg
Volume of ^99mpertechnetate	1 to 3 ml
Radiochemical purity	> 94 %
Storage	1 year at 15°-25°C
Activity per vial	Maximum 11 GBq (300 mCi)
Indications / Posology	Myocardial perfusion scintigraphy : Two injections are generally administered, one during a stress test (exercise or pharmacological stress), and one at rest. The investigation can begin either by rest or by stress test according to the following protocols : • One-day protocol : 400 – 500 MBq for the first injection, three times more for the second injection • Two-day protocol : 600 – 900 MBq per injection Assessment of global ventricular function First-pass technique : 900 - 1100 MBq injected as a bolus at rest or at stress. ECG-triggered, gated SPECT : the administered activity is the same as the recommended activity for myocardial perfusion scintigraphy. Scinti-mammography A single injection of 750 -1000 MBq administered by intravenous injection in an arm vein contralateral to the breast with the suspected abnormality. Parathyroid imaging 200 – 1000 MBq injected as a bolus. The typical activity is 750 MBq.
Stability of labelled product	10h at 2°C - 8°C
Time between injection and examination	Refer to SPC *
Availability	From stock